Variant report
Variant | rs114799793 |
---|---|
Chromosome Location | chr1:154159003-154159004 |
allele | C/T |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:154156200-154163000 | Weak transcription | Psoas Muscle | Psoas |
2 | chr1:154156400-154159400 | Weak transcription | Small Intestine | intestine |
3 | chr1:154156400-154159600 | Weak transcription | GM12878-XiMat | blood |
4 | chr1:154156400-154163200 | Weak transcription | Fetal Muscle Leg | muscle |
5 | chr1:154156400-154164200 | Weak transcription | Primary hematopoietic stem cells | blood |
6 | chr1:154156600-154164200 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
7 | chr1:154156800-154164200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr1:154157200-154164400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
9 | chr1:154158000-154159600 | Enhancers | Hela-S3 | cervix |
10 | chr1:154158200-154159600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr1:154158200-154159800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr1:154158400-154159400 | Enhancers | H1 Cell Line | embryonic stem cell |
13 | chr1:154158400-154159400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr1:154158400-154159600 | Enhancers | HSMM | muscle |
15 | chr1:154158400-154159800 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
16 | chr1:154158400-154159800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
17 | chr1:154158400-154159800 | Enhancers | Fetal Intestine Small | intestine |
18 | chr1:154158400-154160200 | Flanking Active TSS | iPS-18 Cell Line | embryonic stem cell |
19 | chr1:154158400-154160200 | Enhancers | HepG2 | liver |
20 | chr1:154158400-154160400 | Enhancers | Stomach Mucosa | stomach |
21 | chr1:154158400-154160600 | Enhancers | H9 Cell Line | embryonic stem cell |
22 | chr1:154158600-154159400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
23 | chr1:154158600-154160600 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
24 | chr1:154158800-154159200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
25 | chr1:154158800-154159200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
26 | chr1:154158800-154159400 | Enhancers | Skeletal Muscle Female | skeletal muscle |
27 | chr1:154158800-154159600 | Enhancers | Duodenum Mucosa | Duodenum |
28 | chr1:154158800-154159800 | Flanking Active TSS | iPS-15b Cell Line | embryonic stem cell |
29 | chr1:154158800-154159800 | Enhancers | Fetal Intestine Large | intestine |
30 | chr1:154158800-154160000 | Flanking Active TSS | K562 | blood |
31 | chr1:154158800-154160800 | Transcr. at gene 5' and 3' | Skeletal Muscle Male | skeletal muscle |
32 | chr1:154159000-154159400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
33 | chr1:154159000-154159400 | Enhancers | A549 | lung |
34 | chr1:154159000-154159600 | Weak transcription | Pancreas | Pancrea |
35 | chr1:154159000-154159600 | Enhancers | Rectal Mucosa Donor 31 | rectum |
36 | chr1:154159000-154159800 | Flanking Active TSS | ES-I3 Cell Line | embryonic stem cell |
37 | chr1:154159000-154159800 | Flanking Active TSS | HUES6 Cell Line | embryonic stem cell |
38 | chr1:154159000-154159800 | Flanking Active TSS | HUES64 Cell Line | embryonic stem cell |
39 | chr1:154159000-154159800 | Weak transcription | HSMMtube | muscle |
40 | chr1:154159000-154160400 | Flanking Active TSS | HUES48 Cell Line | embryonic stem cell |
41 | chr1:154159000-154164600 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
42 | chr1:154159000-154184400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |